Monitoring and Cognitive Appraisal: The Etiology of Psychological Disorders and The Divergence Between Behavioural and Self-reported Data

St. Franziskus Hospital60 enrolled

Overview

The study investigates the etiology of psychogical disorders from a neuropsychological perspective based on monitoring and cognitive appraisal.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

BASIC_SCIENCE

Masking

DOUBLE

Enrollment

Conditions

Geriatric Patients in a Pre-rehabilitative Treatment Mild Cognitive Impairment (MCI)

Interventions

AX-CPTBEHAVIORAL

administration of the AX-CPT

No InterventionsOTHER

Control group with no intervention treatment

Eligibility

Sex: ALLMin age: 65 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * geriatric patient of the St. Franziskus-Hospital, Germany. Exclusion Criteria: * severe dementia * delirium * psychotic disorders

Locations (1)

St. Franziskus-Hospital Winterberg

Winterberg, North Rhine-Westphalia, Germany

Outcomes

Primary Outcomes

AX-CPT (AX-Continuous Performance Test)

The AX-CPT assesses cognitive control through error rates and reaction times. Range: Error rate: 0-100%; Reaction time: measured in milliseconds Interpretation: Lower error rates and faster reaction times indicate better cognitive control performance.

Time frame: from beginning (day 2) of the hospitalization to the end (day 14) of the biweekly pre-rehabilitative treatment.

CCFQ (Cognitive Control and Flexibility Questionnaire)

The CCFQ measures self-reported cognitive flexibility and control. Scale title: Cognitive Control and Flexibility Questionnaire Range: 1-7 per item Interpretation: Higher scores indicate greater cognitive flexibility and control.

Time frame: Day 1 (pretest) and Day 14 (posttest)

BSI-18 (Brief Symptom Inventory - 18)

T he BSI-18 assesses psychological symptom severity in terms of depression, anxiety, and somatization.T Scale title: Brief Symptom Inventory - 18 Range: 0-4 per item Interpretation: Higher scores indicate greater symptom severity.

Time frame: Day 1 (pretest) and Day 14 (posttest)

MHC-SF (Mental Health Continuum - Short Form)

Measures emotional, psychological, and social well-being. Range: 1-6 per item Interpretation: Higher scores indicate better mental health.

Time frame: Day 1 (pretest) and Day 14 (posttest)

Secondary Outcomes

General Self-Efficacy assessed via General Self-Efficacy Scale (SWE)

Evaluation of perceived self-efficacy across various life domains. Range: 1-4 per item Interpretation: Higher scores indicate greater self-efficacy.

Time frame: Day 1 (pretest) and Day 14 (posttest)

Treatment Beliefs assessed via Palermo Questionnaire

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.